As federal workers like Johnny Zuagar, a statistician at the U. S. Census Bureau, prepare for Christmas, they’re also bracing for potential job furloughs due to government funding issues. With the possibility of a shutdown looming, many are cautious about spending on holiday gifts, worrying about wh
Imagine a fighter jet that can switch from soaring high speeds to long-range cruising in an instant. That's the promise of adaptive engine technology, which aims to power the next generation of combat aircraft. These engines, developed by companies like General Electric (GE) and Pratt & Whitney, are
Women going through postmenopause and suffering from early-stage breast cancer often rely on hormone therapy (HT) to delay cancer's return. But HT comes with side effects that can take a toll on their overall well-being. There's a way to make it better, though. A mix of exercise and health education
Biliary tract cancers are known for their high recurrence rates, even after successful surgery. This makes the future look quite grim for those diagnosed. One common approach to reduce this recurrence risk is to use adjuvant chemotherapy (ACT) after surgery. ACT aims to target and destroy any tiny c
Advanced biliary tract cancer (BTC) is a tough nut to crack. Doctors often turn to second-line treatments like 5-fluorouracil (5FU) and liposomal irinotecan when first-line therapies fail. These drugs have shown promise in improving survival rates. But what if we could make them even more effective?
Infantile epileptic spasms syndrome (IESS) can lead to serious brain development issues. But how does this affect kids' chances of going to elementary school? This study looked into that, focusing on kids who got adrenocorticotropic hormone (ACTH) therapy. ACTH therapy is a common treatment for IES
Did you know that Axiom Space is shaking things up? They've changed their plan for building their commercial space station. By sending the modules in a new order, they can start using a free-flying platform as early as 2028! That's two years ahead of their original plan. Axiom Space has a deal with
Let's talk about a powerful duo in the fight against advanced kidney cancer. Nivolumab and ipilimumab, often called NIVO + IPI, are like the dynamic duo of immunotherapy. They're used to treat people with intermediate- or high-risk advanced or metastatic renal cell carcinoma (mRCC). Now, you might b
Scientists have made a significant discovery in the fight against cancer. They've created new compounds that can destroy specific forms of a protein called NSD2, which plays a role in cancer development. NSD2 comes in three versions due to a process called alternative splicing: long, short, and RE-I
Scientists set out to figure out how various drinks could impact modern dental materials called resin matrix ceramics (RMCs). These materials are used in tooth replacements and are made using computers. The team wanted to know how different liquids that mimic the effect of food and drinks in our mou
